India Pharmaceuticals

Rekvina Laboratories Ltd (526075)

Track

Track

Rekvina Laboratories Ltd recorded four significant insider trading transactions on August 12, 2026. Promoters and directors, including Amit and Surbhit Mukesh Shah, acquired shares totaling 30.67 million INR. These purchases represent the entirety of recent activity, occurring without any reported sales. No specific context regarding the latest earnings report is currently available for this healthcare entity.
Ticker: 526075 Exchange: BSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Promoter Immediate Relative Large shareholder
Through Krima Surbhit Shah, a person closely affiliated to an insider
Transaction date
Purchase
Price
20.16
Quantity 56,139
Value ₹3,386,146
Promoter Immediate Relative Large shareholder
Through Ami Amit Shah, a person closely affiliated to an insider
Transaction date
Purchase
Price
303.88
Quantity 67,135
Value ₹1,167,492
Amit Mukesh Shah Promoter and Director Director Large shareholder
Transaction date
Purchase
Price
128.23
Quantity 52,887
Value ₹1,120,038
Surbhit Mukesh Shah Promoter and Director Director Large shareholder
Transaction date
Purchase
Price
1.00
Quantity 2,099,820
Value ₹2,099,820
Surbhit Shah Large shareholder
Transaction date
Purchase
Price
5.25
Quantity 90,207
Value ₹473,587
Mukesh Shah Large shareholder
Transaction date
Purchase
Price
5.25
Quantity 109,593
Value ₹575,363
Amit Shah Large shareholder
Transaction date
Purchase
Price
5.25
Quantity 90,607
Value ₹475,687
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-12 B Purchase Through Krima Surbhit Shah, a person closely affiliated to an insider Large shareholder
56,139
20.16
₹3,386,146 		56,139 20.16 ₹3,386,146
2026-08-19 2026-08-12 B Purchase Through Ami Amit Shah, a person closely affiliated to an insider Large shareholder
67,135
303.88
₹1,167,492 		67,135 303.88 ₹1,167,492
2026-08-19 2026-08-12 B Purchase
Amit Mukesh Shah

Promoter and Director

Director Large shareholder
52,887
128.23
₹1,120,038 		52,887 128.23 ₹1,120,038
2026-08-19 2026-08-12 B Purchase
Surbhit Mukesh Shah

Promoter and Director

Director Large shareholder
2,099,820
1.00
₹2,099,820 		2,099,820 1.00 ₹2,099,820
2018-06-27 2018-06-26 B Purchase Surbhit Shah Large shareholder
90,207
5.25
₹473,587 		90,207 5.25 ₹473,587
2018-06-27 2018-06-26 B Purchase Mukesh Shah Large shareholder
109,593
5.25
₹575,363 		109,593 5.25 ₹575,363
2018-06-27 2018-06-26 B Purchase Amit Shah Large shareholder
90,607
5.25
₹475,687 		90,607 5.25 ₹475,687
Explore more

More insider trading research around Rekvina Laboratories Ltd

More insider trades in India
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Asia-Pacific